JUN 11, 2015 11:00 AM PDT

Assessing Quality Using ACCURUN® Controls for Quantitative Viral Load Assays

Speakers
  • Chief Scientific Officer, SeraCare Life Sciences
    Biography
      Dr. Garlick is a scientific and R&D leader with over 30 years of experience in the Life Science industry. He has led the development of highly technical R&D projects for new products launched into the research, translational research and diagnostic markets. He has working experience with plasma, cellular and cell based assays using receptor binding, immunoassay, mass spectrometry and molecular diagnostic technologies. At SeraCare Life Sciences, Dr. Garlick is currently leading the new technology development for IVD controls as well as reference materials for NextGen Sequencing applications in oncology, infectious disease, non-invasive prenatal health and genetic testing. When he was at Protein Forest, he led the development of an isoelectric focusing chip for protein and peptide mass spec sample prep, instrument and data analysis software. Previously at NEN DuPont medical products, Dr. Garlick led the effort to develop multiple diagnostics tests used to manage AIDS diagnostics including an HIV antigen assay and an early drug resistance assay. Dr. Garlick has been a member of AACC since 1992, is an Affiliate Member of AACR, and is an Affiliate Scientist with ACMG. He has published 13 peer reviewed papers, and has 2 patents and 2 patent applications.

    Abstract:
    Consistent accuracy in reporting quantitative viral load results is critically important to patients, their physicians and to the clinical laboratory. In clinical practice, quantitative viral load results are used both to diagnose the severity of disease and are crucial for guiding patient management and treatment. Such clinical decision-making relies on the accuracy of clinical laboratory testing. This seminar will provide an overview of quantitative viral load testing and how run controls, when used as part of an overall laboratory quality management system, can help ensure accurate results are reported. Data from HIV-1, HBV and HCV qPCR assays and QC Sigma metrics will be presented.

    Show Resources
    You May Also Like
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    APR 25, 2018 07:00 AM PDT
    C.E. CREDITS
    APR 25, 2018 07:00 AM PDT
    DATE: April 25, 2018TIME: 1500 CET, 10:00 a.m. EST, 7:00 a.m. PST Hematology and coagulation laboratories perform a wide range of routine and specialized tests, allowing clinicians to...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    SEP 12, 2017 08:00 AM PDT
    SEP 12, 2017 08:00 AM PDT
    DATE: September 12, 2017TIME: 8:00am PT, 11:00am ETEvery year, millions of dollars are wasted on poorly characterized and performing antibodies.  Key researchers in the antibody co...
    Loading Comments...